Yahoo Finance
Search documents
Mizuho Lowers Waystar Holding Corp. (WAY) Price Target to $42 Amid Competitive Healthcare Tech Risks
Yahoo Finance· 2026-02-18 06:22
Waystar Holding Corp. (NASDAQ:WAY) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Mizuho Lowers Waystar Holding Corp. (WAY) Price Target to $42 Amid Competitive Healthcare Tech Risks The fourth stock on this list is Waystar Holding Corp. (NASDAQ:WAY). TheFly reported on February 4 that Mizuho lowered its price target on WAY to $42 from $50 while maintaining an Outperform rating. The reduction reflects the firm’s reassessment of competitive risks within the healthcare technolo ...
Western Digital to sell partial stake in Sandisk for $3.17 billion to cut debt
Yahoo Finance· 2026-02-18 06:21
Feb 18 (Reuters) - Western Digital is planning to raise $3.17 billion by selling a part of its stake in flash memory unit Sandisk, which it used to own, as the hard disk drive maker looks to reduce debt. The secondary share sale, announced by Sandisk on Wednesday, is priced at a 7.7% discount to the company's last closing price and involves swapping 5.8 million shares for debt held by affiliates of J.P. Morgan and BofA Securities. Following the share sale, Western Digital's stake in Sandisk will b ...
Haemonetics Corporation (HAE) Q3 Performance Prompts Baird Model Update, Price Target Falls to $81
Yahoo Finance· 2026-02-18 06:13
Haemonetics Corporation (NYSE:HAE) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Haemonetics Corporation (HAE) Q3 Performance Prompts Baird Model Update, Price Target Falls to $81 Haemonetics Corporation (NYSE:HAE) is among the most innovative healthcare stocks. TheFly reported on February 6 that Baird lowered its price target for HAE to $81 from $99 while maintaining an Outperform rating. The firm updated its model following the company’s Q3 results and lowered the estimate ...
Truist Notes Operational Investments For Cytokinetics, Incorporated (CYTK) to Support Short-Term Growth
Yahoo Finance· 2026-02-18 06:11
Cytokinetics, Incorporated (NASDAQ:CYTK) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Truist Notes Operational Investments For Cytokinetics, Incorporated (CYTK) to Support Short-Term Growth Cytokinetics, Incorporated (NASDAQ:CYTK) is one of the fifteen best healthcare stocks on our list. TheFly reported on February 3 that Truist raised its price target on CYTK to $92 from $84 and maintained a Buy rating. The company revised its model ahead of its Q4 results to account for t ...
TBIL Rang the Opening Bell on Dual Share Classes. What Comes Next?
Yahoo Finance· 2026-02-18 05:03
The dual share class race is on, and F/m is in pole position. The long-awaited dual share class structure made its official debut last week when Texas-based F/m Investments announced that its US Treasury 3-Month Bill ETF (TBIL) will offer both ETF and mutual fund share classes. The announcement marks the first time a firm has successfully launched the dual share class structure, an idea that has percolated across the industry since Vanguard’s patent on the model expired in 2023. The move is the first step ...
Why Buffer ETFs May Fall Short for Long-Term Investors
Yahoo Finance· 2026-02-18 05:02
Some ETFs have “buff” in their names, but that doesn’t mean they’re strong performers. Buffer funds have become the largest category within ETFs by number of products, and they are among the fastest growing by assets. By employing options, they offer protection from losses, but that doesn’t necessarily serve most long-term investors well, according to a recent report from Morningstar. “They definitely fit best with investors that have shorter time horizons,” said Zachary Evens, Morningstar manager resea ...
Cruising for Trouble: Activist Investor Elliott Chastises Norwegian Board for CEO Picks
Yahoo Finance· 2026-02-18 05:01
It’s anything but smooth sailing for Norwegian Cruise Line and its new CEO. The company, which has struggled recently to keep up with rivals like Royal Caribbean and Carnival, announced last week that former Subway Restaurants chief executive John Chidsey was taking over as CEO, effective immediately. Stocks fell more than 7% on Friday after the news, and that wasn’t the worst of it. On Tuesday, activist investor Elliott Investment Management, which says it now holds a stake of more than 10% in Norwegian ...
Nvidia leads the US stock market higher
Yahoo Finance· 2026-02-18 04:55
NEW YORK (AP) — The U.S. stock market ticked higher on Wednesday, led by its most influential stock, Nvidia. The S&P 500 rose 0.6% and pulled a bit closer to its all-time high set late last month. The Dow Jones Industrial Average added 129 points, or 0.3%, and the Nasdaq composite gained 0.8%. Nvidia helped lift the market and climbed 1.6% after Meta Platforms announced a long-term partnership where it will use millions of chips and other equipment from Nvidia for its artificial-intelligence data centers ...
Roth Capital Raises its Price Target on TKO Group Holdings, Inc. (TKO) to $240 and Maintains a Buy Rating
Yahoo Finance· 2026-02-18 04:46
TKO Group Holdings, Inc. (NYSE:TKO) is among the 11 Best Entertainment Stocks to Buy According to Wall Street. Roth Capital Raises its Price Target on TKO Group Holdings, Inc. (TKO) to $240 and Maintains a Buy Rating On February 12, 2026, Roth Capital raised its price target on TKO Group Holdings, Inc. (NYSE:TKO) to $240 from $210 and maintained a Buy rating. The firm said it remains constructive on TKO’s long-term growth outlook and noted that while the company has completed negotiations for its three m ...
Morgan Stanley Raises its Price Target on Sphere Entertainment Co. (SPHR) to $135 and Maintains an Overweight Rating
Yahoo Finance· 2026-02-18 04:45
Sphere Entertainment Co. (NYSE:SPHR) is among the 11 Best Entertainment Stocks to Buy According to Wall Street. Morgan Stanley Raises its Price Target on Sphere Entertainment Co. (SPHR) to $135 and Maintains an Overweight Rating On February 13, 2026, Morgan Stanley raised its price target on Sphere Entertainment Co. (NYSE:SPHR) to $135 from $105 and maintained an Overweight rating, citing stronger-than-expected results from The Wizard of Oz. The firm said the performance lifts its estimates for the Las V ...